Skip to content
46

ass

Skip it

Soft demand (-17.8% this quarter) — this niche doesn't clear our bar today.

Market size 38Growth 16Conversion 84Competition 48Returns 100Price range 37Avg price 21Brand share 37Review moat 74Quality gap 18

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Great9.2%

search→purchase rate — share of searches ending in a sale

Review moat

Good539.71

avg incumbent reviews — the moat a new listing must climb

Competition

Okay56%

top-5 click share — leaders hold, buyers still browse

Market size

Okay€190K

€190K/yr · 268K searches

Brand share

Okay83%

top-5 brand share — brands hold most of the demand

Price range

Okay€4.04–€21.37

cheapest to priciest tracked listing — scored on the share inside $15–$100

Avg price

Bad€7.70

avg listing price — sweet spot $15–$100

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Growth

Bad-17.8%

90-day search growth — must beat 0% to launch

Competition

The top 5 products take 56% of clicks — established leaders, but buyers still shop beyond them.

Brands

10 falling

Sellers

25

Top-5 brand share

83%

Open market

11%

  • ratiopharm33%
  • 1A PHARMA19%
  • apo-discounter.de17%
  • Hexal8%
  • Faar Apo6%
  • vitenda6%
  • Open — no brand owns it (4 brands, 11%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%5%€10K10%€19K15%€29K20%€38K1101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 17 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 66 weeks — -17.8% search growth over the last 90 days.
8K6KSpike '25Black Friday '25Spike '26AprMayJunJulAugSepOctNovDecJanFebMarAprMayJun

Peak months: Jan · busiest ÷ quietest = 2.6×

Reviews

What buyers praise and complain about, mined from review topics.

Top return reasons

Dosierung50%
beworben Vs Tatsächliches Produkt50%